Viveve Reports Fourth Quarter and Full Year 2017 Financial Results

Medical Device Investing

Viveve Medical (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today reported financial results for the three months and year ended December 31, 2017. As quoted in the press release: “Our successful fourth-quarter results completed a remarkable year for Viveve, underscoring the scope of our commercial opportunity and the outstanding execution delivered by …

Viveve Medical (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today reported financial results for the three months and year ended December 31, 2017.

As quoted in the press release:

“Our successful fourth-quarter results completed a remarkable year for Viveve, underscoring the scope of our commercial opportunity and the outstanding execution delivered by our team in every area of our operations throughout the year. During 2017 we rigorously pursued and achieved several key milestones supporting our global commercialization goals,” said Ms. Patricia Scheller, chief executive officer and director of Viveve. “We believe these achievements further solidify our position as a leader in technologies to support women’s intimate health and will allow us to capitalize on the increasing demand, rapid adoption, and expanded utilization of our products in 2018.”

Click here to read the full press release.

The Conversation (0)
×